Search alternatives:
significant degs » significant genes (Expand Search), significant adverse (Expand Search), significant cause (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
degs increase » drugs increased (Expand Search), peaks increase (Expand Search), bems increased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
significant degs » significant genes (Expand Search), significant adverse (Expand Search), significant cause (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
degs increase » drugs increased (Expand Search), peaks increase (Expand Search), bems increased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
1
-
2
The profile of the 263 significant differentially expressed metabolites (DEMs).
Published 2021Subjects: -
3
-
4
-
5
-
6
-
7
Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
Published 2024“…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
Published 2024“…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”
-
15
-
16
-
17
-
18
-
19
-
20